GeneDx Holdings Corp. Class A Common Stock
WGSGeneDx Holdings Corp. Class A (WGS) is a biotechnology company specializing in genetic testing and diagnostics. It offers comprehensive genomic services, including whole genome sequencing, genetic variant analysis, and clinical testing to support personalized medicine and rare disease diagnosis. The company focuses on leveraging advanced genomic technologies to aid healthcare providers and researchers in identifying genetic conditions.
Company News
GeneDX CEO Katherine Stueland sold 2,158 shares on October 29, 2025, primarily to cover tax obligations after converting restricted stock units. The transaction was part of routine accounting and does not indicate a loss of confidence in the company.
Multiple health care stocks experienced significant options trading activity, with various bullish and bearish signals across different companies in the sector.
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. after a Grizzly Research report alleged widespread fraud, causing the stock to drop 6.7%.
